NCT00004895已完成2 期
Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
RATIONALE: Palliative therapy with octreotide may help patients who have bowel obstruction that cannot be removed by surgery to live longer and more comfortably.
PURPOSE: Phase II trial to study the effectiveness of octreotide as palliative therapy in treating patients who have cancer-related bowel obstruction that cannot be removed by surgery.
详细描述
OBJECTIVES:
- Determine the effectiveness of octreotide in the palliation of bowel obstruction secondary to cancer.
- Characterize the dose and tolerability of octreotide in this patient population.
OUTLINE: Patients receive octreotide subcutaneously or IV over 24 hours on days 2-5.
Patients who respond well to study may continue octreotide for palliative effects.
PROJECTED ACCRUAL: A total of 9-25 patients will be accrued for this study over 9 months.
研究设计
- 研究类型
- Interventional
- 主要目的
- Supportive Care
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the PelvisDiarrheaEndometrial CancerColorectal CancerCervical CancerFallopian Tube CancerUnspecified Adult Solid Tumor, Protocol SpecificProstate CancerOvarian CancerSarcomaVaginal CancerVulvar CancerNCT00033605Alliance for Clinical Trials in Oncology130
已完成
3 期
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal CancerDrug/Agent Toxicity by Tissue/OrganColorectal CancerAnal CancerRadiation EnteritisNCT00075868Radiation Therapy Oncology Group233
已完成
2 期
Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric CancerGastric CancerEsophageal CancerNCT04871204Fredrik Klevebro20
已完成
3 期
Octreotide in Treating Patients With Cancer-Related Malignant AscitesMetastatic CancerUnspecified Adult Solid Tumor, Protocol SpecificNCT00182754Alliance for Clinical Trials in Oncology33
终止
2 期
Palliative Management of Inoperable Malignant Bowel ObstructionMalignant Bowel ObstructionNCT04027348Roswell Park Cancer Institute15